H&H國際控股(01112.HK):前九月總收入增長3.1%至77.68億元
格隆匯 11 月 5日丨H&H國際控股(01112.HK)發佈公告,截至2020年9月30日止九個月,總收入按同類比較基準增長3.1%至人民幣77.676億元;儘管線下流量因2019新冠肺炎而放緩,但歸屬於中國的收入仍然保持強勁,同比增長11.0%,佔集團總收入的82.5%;嬰幼兒配方奶粉銷售增長2.2%,主要隨着中國擴展渠道及推出新國產系列而受2020年第三季度同比正增長13.2%的支持。
截至2020年9月30日止九個月,整體成人營養及護理用品業務於澳洲及新西蘭(“澳新”)市場按同類比較基準下跌32.1%,預計於下半年餘下時間持續下跌。然而,於九個月回顧期內,於中國及其他市場仍然持續增長,分別增長23.9%及1.6%。此外,因產品的變動、渠道及市場的組合變動(包括於澳新市場的負面經營槓桿效應)帶來的利潤率壓力持續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.